Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adherence and the Role of Coagulation Assays in Patients Treated With Dabigatran Etexilate for Non-valvular Atrial Fibrillation

NCT03280368 is registered in ClinicalTrials.gov with Hospitalsenheden Vest as lead sponsor.

NCT NCT03280368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03280368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adherence and the Role of Coagulation Assays in Patients Treated With Dabigatran Etexilate for Non-valvular Atrial Fibrillation
Lead sponsor
Hospitalsenheden Vest
Phase
Observational
Overall status
Completed
Start date
June 30, 2014
Completion date
January 31, 2020
Enrollment
430 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants; circulating, hemorrhagic disorder, atrial fibrillation, bleeding, blood clot, blood coagulation disorder, blood coagulation tests, drug effect, drug intolerance, drug toxicity, drug use, laboratory problem, medication adherence, thrombosis